NASDAQ: SNYR
Synergy Chc Corp Stock

$0.19+0.00 (+0%)
Updated Jul 20, 2026
SNYR Price
$0.19
Fair Value Price
N/A
Market Cap
$2.76M
52 Week Low
$0.18
52 Week High
$4.00
P/E
-0.12x
P/B
-0.11x
P/S
0.53x
PEG
N/A
Dividend Yield
N/A
Revenue
$27.70M
Earnings
-$15.79M
Gross Margin
65.4%
Operating Margin
-31.84%
Profit Margin
-57%
Debt to Equity
-1.25
Operating Cash Flow
-$4M
Beta
0.18
Next Earnings
Aug 13, 2026
Ex-Dividend
N/A
Next Dividend
N/A

SNYR Overview

Synergy CHC Corp. operates as a distributor of diverse consumer health, beauty, and lifestyle merchandise across the United States, Canada, and the United Kingdom. The company's brand portfolio features FOCUSfactor, specializing in nutritional supplements aimed at enhancing brain function. It also offers the Flat Tummy line, which includes a range of wellness and fashion items such as specialty teas, meal replacement shakes, lollipops, dietary aids, apparel, and exercise accessories. Furthermore, under the Hand MD brand, Synergy CHC Corp. provides anti-aging skincare products, encompassing serums and creams designed for exfoliation, skin repair, and rehydration, as well as hand hygiene products like soaps and sanitizers. These goods are made available to consumers through conventional retail partners and significant television advertising campaigns. The company's skincare range, in particular, is also sold directly via online platforms. Founded in 2010, the firm was originally named Synergy Strips Corp. and rebranded to Synergy CHC Corp. in August 2015. Its primary business operations are based in Westbrook, Maine.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine SNYR's potential to beat the market

Zen Rating Component Grades

N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Medical Distribution

Industry Rating
A
SNYR
Ranked
Unranked of 5

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
$225.75A
$86.20C
$303.99C
View Top Medical Distribution Stocks

Be the first to know about important SNYR news, forecast changes, insider trades & much more!

SNYR News

Overview

Due Diligence Score

Industry Average (25)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how SNYR scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

SNYR is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
SNYR is unprofitable, so we are unable to assess its PEG ratio
PEG Value Valuation
SNYR's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
There are 30 more SNYR due diligence checks available for Premium users.

Valuation

SNYR price to earnings (PE)

For valuing profitable companies with steady earnings

Company
-0.12x
Industry
25x
Market
11.71x

SNYR price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
-0.11x
Industry
159.7x

SNYR's financial health

Profit margin

Revenue
$5.5M
Net Income
-$2.6M
Profit Margin
-46.8%
SNYR's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
SNYR's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$6.5M
Liabilities
$31.9M
Debt to equity
-1.25
SNYR's short-term liabilities ($6.85M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
SNYR's long-term liabilities ($25.02M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
SNYR's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
SNYR's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$2.0M
Investing
$0.0
Financing
-$307.6k
SNYR's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

SNYR vs Medical Distribution Stocks

TickerZen RatingMarket Cap1d %P/EP/B
SNYR$2.76M-0.54%-0.12x-0.11x
COSM$12.52M-2.13%-0.36x0.63x
FOCL$210.27M+3.22%-5.75x17.69x
ACHC$254.26M-4.32%-0.24x-0.55x
AHG$1.35B+4.64%-3.27x6.82x

Synergy Chc Stock FAQ

What is Synergy Chc's quote symbol?

(NASDAQ: SNYR) Synergy Chc trades on the NASDAQ under the ticker symbol SNYR. Synergy Chc stock quotes can also be displayed as NASDAQ: SNYR.

If you're new to stock investing, here's how to buy Synergy Chc stock.

What is the 52 week high and low for Synergy Chc (NASDAQ: SNYR)?

(NASDAQ: SNYR) Synergy Chc's 52-week high was $4.00, and its 52-week low was $0.18. It is currently -95.38% from its 52-week high and 2.21% from its 52-week low.

How much is Synergy Chc stock worth today?

(NASDAQ: SNYR) Synergy Chc currently has 14,899,883 outstanding shares. With Synergy Chc stock trading at $0.19 per share, the total value of Synergy Chc stock (market capitalization) is $2.76M.

Synergy Chc stock was originally listed at a price of $9.00 in Oct 23, 2024. If you had invested in Synergy Chc stock at $9.00, your return over the last year would have been -97.94% (not including any dividends or dividend reinvestments).

How much is Synergy Chc's stock price per share?

(NASDAQ: SNYR) Synergy Chc stock price per share is $0.19 today (as of Jul 20, 2026).

What is Synergy Chc's Market Cap?

(NASDAQ: SNYR) Synergy Chc's market cap is $2.76M, as of Jul 21, 2026.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Synergy Chc's market cap is calculated by multiplying SNYR's current stock price of $0.19 by SNYR's total outstanding shares of 14,899,883.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.